Thoracic organ transplantation in the United States, 1994-2003

Mark L Barr1, Robert C Bourge, Jonathan B Orens

  • 1University of Southern California, Los Angeles, CA, USA. mbarr@surgery.usc.edu

Insights

Thoracic organ transplantation shows mixed trends. Heart transplant wait times increased, but death rates declined. Lung transplant waiting lists grew, yet survival rates improved, prompting a new allocation system to reduce waitlist deaths.

Area of Science:

  • Medicine
  • Transplantation Surgery
  • Public Health

Background:

  • Thoracic organ transplantation is a critical treatment for end-stage organ failure.
  • The Organ Procurement and Transplantation Network (OPTN) and Scientific Registry of Transplant Recipients (SRTR) provide vital data on transplantation outcomes.
  • Understanding trends in waiting lists and survival rates is crucial for improving patient management and allocation policies.

Purpose of the Study:

  • To review the state of thoracic organ transplantation in 2003 and the preceding decade using OPTN/SRTR data.
  • To analyze trends in waiting list duration, patient survival, and organ allocation policies for heart, lung, and heart-lung transplants.
  • To evaluate the impact of these trends on patient outcomes and identify areas for policy improvement.

Main Methods:

  • Analysis of OPTN/SRTR data from 1994 to 2003.
  • Review of waiting list statistics, including patient numbers and time to transplantation.
  • Examination of patient survival rates post-transplantation and trends in waiting list mortality.
  • Assessment of changes in organ allocation policies, including the introduction of a new lung allocation system.

Main Results:

  • Significant increase in time spent on the heart transplant waiting list, with over 49% waiting more than two years by 2003.
  • General decline in heart waiting list death rates over the decade.
  • Record high for the lung transplant waiting list in 2003 (3,836 registrants), more than tripling since 1994.
  • Statistically significant improvement in one-year patient survival for lung recipients in 2002 (82%) compared to 2001 (78%).
  • Declining numbers for heart-lung transplant waiting lists, but adjusted patient survival remains worse than for isolated lung recipients, particularly for those with congenital heart disease.

Conclusions:

  • The landscape of thoracic organ transplantation has evolved, with increasing wait times for heart transplants but improved survival rates.
  • The lung transplant waiting list has expanded significantly, necessitating policy changes to optimize organ allocation and reduce mortality.
  • A new lung allocation system, implemented in 2004, aims to prioritize patients based on survival benefit and urgency, addressing the goal of minimizing deaths on the waiting list.